Please wait

 

 

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

For the Three Months Ended March 31, 2026

(Unaudited and Expressed in US Dollars)

 

POET TECHNOLOGIES INC.

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

Page 1

 

 

POET TECHNOLOGIES INC.

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Expressed in US Dollars)

(Unaudited)

 

  

March 31,

2026

  

December 31,

2025

 
         
Assets   
Current          
Cash and cash equivalents (Note 2)  $16,537,393   $39,959,201 
Short-term investments (Note 2)   412,599,049    273,439,102 
Accounts receivable (Note 10)   290,368    - 
Prepaids and other current assets (Note 4)   1,556,327    1,063,528 
    430,983,137    314,461,831 
Long term deposit (Note 15)   208,125    208,125 
Loan receivable (Note 22)   15,194,384    - 
Property and equipment (Note 6)   13,812,226    12,233,828 
Patents and licenses (Note 7)   534,430    556,375 
Right of use assets (Note 8)   1,039,559    1,112,279 
   $461,771,861   $328,572,438 
           
Liabilities   
Current          
Accounts payable and accrued liabilities (Note 9)  $3,275,397   $1,639,543 
Convertible debt (Note 5)   5,800,000    5,800,000 
Lease liability (Note 8)   265,256    236,304 
Derivative warrant liability (Note 21)   2,584,759    135,631,585 
Contract liability (Note 10)   247,505    445,840 
    12,172,917    143,753,272 
Non-current lease liability (Note 8)   955,344    1,029,894 
    13,128,261    144,783,166 
           

Shareholders’ Equity

 

 
Share capital (Note 11(b))   586,086,286    443,076,163 
Warrants (Note 12)   162,044,130    30,599,602 
Contributed surplus (Note 13)   12,397,616    9,329,724 
Accumulated other comprehensive loss   (2,446,012)   (2,121,883)
Deficit   (309,438,420)   (297,094,334)
    448,643,600    183,789,272 
   $461,771,861   $328,572,438 

 

Commitments and contingencies (Note 15)
 
Subsequent events (Notes 23)
 
On behalf of the Board of Directors

 

/s/ Suresh Venkatesan /s/ Robert Tirva
Director  Director

  

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

Page 2

 

 

POET TECHNOLOGIES INC.

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND DEFICIT

(Expressed in US Dollars)

 

  

Three Months Ended

March 31,

 
   2026   2025 
         
Revenue (Note 3)  $503,389   $166,760 
           
Operating expenses          

Selling, marketing and administration (Note 20)

   12,533,213    5,189,062 
Research and development (Note 20)   5,840,334    4,514,107 
Operating expenses   18,373,547    9,703,169 
Operating loss before the following   (17,870,158)   (9,536,409)
Interest expense (Note 8)   (46,517)   (32,786)
Other income, including interest   3,970,291    527,782 
Fair value adjustment to derivative warrant liability (Note 21)   1,602,298    15,382,971 
Net income (loss)   (12,344,086)   6,341,558 
           

Deficit, beginning of period

   (297,094,334)   (270,986,848)
Net income (loss)   (12,344,086)   6,341,558 
           
Deficit, end of period  $(309,438,420)  $(264,645,290)
           
Basic and diluted income (loss) per share (Note 14)  $(0.08)  $0.08 

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Expressed in US Dollars)

 

  

Three Months Ended

March 31,

 
   2026   2025 
         

Net income (loss)

  $(12,344,086)  $6,341,558 
Other comprehensive income (loss)          
Exchange differences on translating foreign operations   (324,129)   164,831 
Comprehensive income (loss)  $(12,668,215)  $6,506,389 

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

Page 3

 

 

POET TECHNOLOGIES INC.

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Expressed in US Dollars)

 

For the Three Months Ended March 31,  2026   2025 
Share Capital          
Beginning balance  $443,076,163   $223,742,335 
Funds from the exercise of warrants   -    4,197,030 
Fair value assigned to warrants exercised   -    1,881,195 
Funds from the exercise of stock options   248,245    155,655 
Fair value assigned to stock options exercised   418,874    386,914 
Funds from common shares issued on private placement or public offerings   150,000,006    - 
Share issue costs   (7,657,002)   - 
March 31,   586,086,286    230,363,129 
Warrants          
Beginning balance   30,599,602    11,157,738 
Fair value of warrants reclassified from derivative warrant liability   131,444,528    - 
Fair value assigned to warrants exercised   -    (1,814,738)
March 31,   162,044,130    9,343,000 
Contributed Surplus          
Beginning balance   9,329,724    58,724,750 
Stock-based compensation   3,486,766    841,793 
Fair value of stock options exercised   (418,874)   (386,914)
March 31,   12,397,616    59,179,629 
Accumulated Other Comprehensive Loss          
Beginning balance   (2,121,883)   (1,949,088)
Other comprehensive loss attributable to common shareholders - translation adjustment   (324,129)   164,831 
March 31,   (2,446,012)   (1,784,257)
Deficit          
Beginning balance   (297,094,334)   (270,986,848)
Net income (loss)   (12,344,086)   6,341,558 
March 31,   (309,438,420)   (264,645,290)
Total shareholders’ equity  $448,643,600   $32,456,211 

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

Page 4

 

 

POET TECHNOLOGIES INC.

 

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in US Dollars)

 

For the Three Months Ended March 31,  2026   2025 
         
CASH (USED IN) PROVIDED BY:          
           
OPERATING ACTIVITIES          
           
Net income (loss)  $(12,344,086)  $6,341,558 
Adjustments for:           
Depreciation of property and equipment (Note 6)   860,729    634,080 
Amortization of right of use asset (Note 8)   75,026    69,116 
Amortization of patents and licenses (Note 7)   21,945    23,672 
Non-cash interest   46,538    19,120 
Stock-based compensation (Note 13)   3,486,766    841,793 
Gain on lease modification   -    (10,978)
Fair value adjustment to derivative warrant liability (Note 21)   (1,602,298)   (15,382,971)
    (9,455,380)   (7,464,610)

Net change in non-cash working capital accounts:

          
Accounts receivable   (292,571)   - 
Prepaid and other current assets   (492,934)   (217,086)
Accounts payable and accrued liabilities   1,631,210    (1,572,732)
Contract liabilities   (199,898)   274,926 
Cash flows used in operating activities   (8,809,573)   (8,979,502)
INVESTING ACTIVITIES          
Purchase of short-term investments   (167,159,947)   (16,096,218)
Proceeds from the sale of short-term investments   28,000,000    - 
Purchase of property and equipment (Note 6)   (2,434,925)   (522,523)
Loan receivable (Note 22)   (15,194,384)   - 
Cash flows used in investing activities   (156,789,256)   (16,618,741)
FINANCING ACTIVITIES          
Issue of common shares, net of share issue costs (Note 11)   142,591,249    4,352,685 
Payment of lease liability (Note 8)   (93,902)   (35,289)
Cash flows from financing activities   142,497,347    4,317,396 
           

EFFECT OF EXCHANGE RATE CHANGES ON CASH

   (320,326)   37,513 
           

NET CHANGE IN CASH AND CASH EQUIVALENTS

   (23,421,808)   (21,243,334)
CASH AND CASH EQUIVALENTS, beginning of period   39,959,201    37,143,759 
           
CASH AND CASH EQUIVALENTS, end of period  $16,537,393   $15,900,425 

 

Cash and cash equivalents consist of cash in current accounts of $7,106,128 (2025 - $1,759,709) and funds invested in US and Canadian Term Deposits and high interest savings accounts of $9,431,265 (2025 - $38,199,492) earning interest at rates ranging from 2.25% - 3.24% and maturing in less than one year.

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

Page 5

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

1. NATURE OF OPERATIONS

 

POET Technologies Inc. is incorporated in the Province of Ontario. POET Technologies Inc. and its subsidiaries (the “Company”) design and develop the POET Optical Interposer and Photonic Integrated Circuits for the data center and tele-communications markets. The Company’s common shares are listed on the Nasdaq under the symbol “POET”. The Company’s head office is located at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada M4P 1E2. These audited consolidated financial statements of the Company were approved by the Board of Directors of the Company on May 14, 2026.

 

These consolidated financial statements have been prepared using IFRS Accounting Standards (“IFRS”) applicable to a going concern, which assumes that the Company will be able to realize its assets, discharge its liabilities and continue in operation for the following twelve months.

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION

 

These condensed unaudited consolidated financial statements of the Company and its subsidiaries were prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (“IASB”).

 

These condensed unaudited consolidated financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated audited financial statements for the year ended December 31, 2025.

 

The preparation of financial statements in accordance with International Accounting Standards (“IAS”) 34 Interim Financial Reporting, requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company’s accounting policies disclosed in Note 2 of its consolidated financial statements for the year ended December 31, 2025. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:

 

Basis of consolidation

 

These consolidated financial statements include the accounts of POET Technologies Inc. and its subsidiaries; ODIS Inc. (“ODIS”), Opel Solar Inc. (“OPEL”), BB Photonics Inc. (“BB Photonics”), POET Technologies Pte Ltd. (“PTS”), POET Optoelectronics Shenzhen Co., Ltd (“POET Shenzhen”), POET Technologies Sdn. Bhd. (“PTM”), and Super Photonics Xiamen Co., Ltd (“SPX”). Subsidiaries are all entities over which the Company has exposure to variable returns from its involvement and has the ability to use power over the investee to affect its returns. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company until the date on which control ceases. The accounts of subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies. All intercompany balances and transactions have been eliminated on consolidation.

 

The preparation of financial statements in accordance with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:

 

Critical accounting judgments and significant estimates and uncertainties

 

Business combinations

 

Acquisitions of businesses are accounted for using the acquisition method. The acquisition cost is measured at the acquisition date at the fair value of the consideration transferred, including all contingent consideration.

 

Page 6

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

 

The determination of whether a corporate entity or set of assets acquired, and liabilities assumed, constitute a business may require the Company to make certain judgements, considering all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits. SPX was determined to constitute an acquisition of assets.

 

Determination of functional currency

 

The Company determines the functional currency through an analysis of several indicators such as expenses and cash flow, financing activities, retention of operating cash flows, and frequency of transactions within the reporting entity.

 

Valuation of share-based compensation

 

The Company uses the Black-Scholes Option Pricing Model for valuation of share-based compensation and derivative warrant liability. Option pricing models require the input of subjective assumptions including expected price volatility, risk-free interest rate, and forfeiture rate. Changes in the input assumptions can materially affect the fair value estimate and the Company’s earnings and equity reserves.

 

Income taxes

 

In assessing the probability of realizing income tax assets, management makes estimates related to expectation of future taxable income, applicable tax opportunities, expected timing of reversals of existing temporary differences and the likelihood that tax positions taken will be sustained upon examination by applicable tax authorities. In making its assessments, management gives additional weight to positive and negative evidence that can be objectively verified.

 

Foreign currency translation

 

These consolidated financial statements are presented in U.S. dollars (“USD”), which is the Company’s presentation currency.

 

Items included in the financial statements of each of the Company’s subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”). Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity are recognized in the statement of operations and deficit.

 

The following table presents the jurisdiction under which each entity in the group is incorporated and the functional currency of each entity:

 

Entity   Incorporating Jurisdiction   Functional Currency
POET Technologies Inc   Canada   US dollars (1)
ODIS   United States of America   US dollars
OPEL   United States of America   US dollars
BB Photonics   United States of America   US dollars
PTS   Singapore   Singapore dollar
PTM   Malaysia   Malaysian Ringgit
POET Shenzhen   China   Renminbi
SPX   China   Renminbi

 

Assets and liabilities of entities with functional currencies other than U.S. dollars are translated into the presentation currency at the year end rates of exchange, and the results of their operations are translated at average rates of exchange for the year. The resulting translation adjustments are included in accumulated other comprehensive loss in shareholders’ equity. Additionally, foreign exchange gains and losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive loss. Elements of equity are translated at historical rates.

 

(1) Effective October 1, 2025, management determined that the Canadian entity’s functional currency changed from the Canadian dollar to the U.S. dollar due to a shift in the primary economic environment, being the change in primary sources of funding of the Canadian entity. In accordance with IAS 21, the change was applied prospectively. All assets, liabilities, and equity were translated into U.S. dollars using the exchange rate on the date of change, and these amounts became the new historical carrying values.

 

Page 7

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

 

This resulted in adjustments of ($28,058,114) to share capital, ($204,117) to warrants, ($8,255,576) to contributed surplus and $36,855,727 to deficit. Further, changes to the derivative warrant liability (note 10), resulted in adjustments of ($14,961,966) to warrants and ($35,732,933) to contributed surplus. These amounts are presented as “adjustment due to change in functional currency” on the consolidated statements of changes in shareholders’ equity.

 

Financial Instruments

 

Financial assets held with an objective to hold assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest are measured at amortised cost using the effective interest method. Debt investments held with an objective to hold both assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest as well as selling the asset on the basis of fair value are measured at FVTOCI. All other financial assets are classified and measured at fair value through profit or loss (“FVTPL”). Financial liabilities are classified as either FVTPL or other financial liabilities, and the portion of the change in fair value that relates to the Company’s credit risk is presented in other comprehensive income (loss). Instruments classified as FVTPL are measured at fair value with unrealized gains and losses recognized in net income (loss). Other financial liabilities are subsequently measured at amortised cost using the effective interest method.

 

Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities, other than financial assets and financial liabilities classified as FVTPL, are added to or deducted from the fair value on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified as FVTPL are recognized immediately in consolidated net income (loss).

 

Financial assets

 

The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire, or it transfers the rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of the financial asset are transferred or in which the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset. Any interest in transferred financial assets that is created or retained by the Company is recognized as a separate asset or liability.

 

Financial liabilities

 

A financial liability is derecognized from the statement of financial position when it is extinguished, that is, when the obligation specified in the contract is either discharged, cancelled or expires. Where there has been an exchange between an existing borrower and lender of debt instruments with substantially different terms, or there has been a substantial modification of the terms of an existing financial liability, this transaction is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. A gain or loss from extinguishment of the original financial liability is recognized in profit or loss.

 

The Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, deposit, loan receivable, accounts payable and accrued liabilities, convertible debt, derivative warrant liability and contract liabilities.

 

Page 8

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

 

Impairment of long-lived assets

 

The Company’s tangible and intangible assets are reviewed for indications of impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. An assessment is made at each reporting date whether there is any indication that an asset may be impaired.

 

An impairment loss is recognized when the carrying amount of an asset exceeds its recoverable amount. Impairment losses are recognized in profit and loss for the year. The recoverable amount is the greater of the asset’s fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit (“CGU”) to which the asset belongs.

 

An impairment loss is reversed if there is an indication that there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. No impairment loss has been reported for the current period.

 

Derivative financial instruments

 

The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments. Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.

 

The following table outlines the classification of financial instruments under IFRS 9:

 

Financial Assets

 

Cash and cash equivalents   Amortized cost
Short-term investments   Amortized cost
Accounts receivable   Amortized cost
Loan receivable   Fair value through profit and loss (FVTPL)

 

Financial Liabilities

 

Accounts payable and accrued liabilities   Amortized cost
Convertible debt   Amortized cost
Derivative warrant liability   Fair value through profit and loss (FVTPL)

 

Cash and cash equivalents

 

Cash and cash equivalents include cash on hand, bank deposits, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash.

 

Short-term investments

 

The short-term investments of $412,599,049 (2025 - $273,439,102) consist of guaranteed investment certificates (GICs) held with Canadian chartered banks and earn interest at rates ranging from 3.4% to 4.91%, that mature within one year.

 

Page 9

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

 

Property and equipment

 

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

 

  Machinery and equipment Straight Line, 5 years
  Leasehold improvements Straight Line, term of the lease
  Office equipment Straight Line, 3 - 5 years

 

Patents and licenses

 

Patents and licenses are recorded at cost and amortized on a straight line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

 

Revenue recognition

 

Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties. The Company recognizes revenue when it transfers control over a product or service to a customer.

 

Sale of goods

 

Revenue from the sale of goods is recognized, net of discounts and customer rebates, at the point in time the transfer of control of the related products has taken place as specified in the sales contract and collectability is reasonably assured.

 

Service revenue

 

The Company provides contract services, primarily in the form of non-recurring revenue (“NRE”) where control is passed to the customer over time. The contracts generally provide agreed upon milestones for customer payment which include but are not limited to the delivery of sample products, design reports and test reports. The customer makes payment when it has approved the delivery of the milestone. The Company must determine if the contract is made up of a series of independent performance obligations or a single performance obligation. Where NRE contracts contain multiple performance obligations for which a standalone transaction price can be assessed, revenue is recognized as each performance obligation is satisfied. Where NRE contracts contain a single performance obligation to be settled over time, revenue is recognized progressively based on the output method.

 

Other income

 

Interest income

 

Interest income on cash and cash equivalents, short-term investments and loan receivable is recognized as earned using the effective interest method.

 

Stock-based compensation

 

Stock options awarded to non employees are measured using the fair value of the goods or services received unless that fair value cannot be estimated reliably, in which case measurement is based on the fair value of the stock options. Stock options awarded to employees are accounted for using the fair value method. The fair value of such stock options granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant. When stock options are exercised, the proceeds received, together with any related amount in the reserves, are credited to share capital. In the event share options are forfeited prior to vesting, the associated fair value recorded to date is reversed.

 

Page 10

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2. SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

 

Valuation of equity units issued in private placements

 

When the Company issues warrants that are exercisable in the Company’s functional currency, the proceeds from the issue of units is allocated between common shares and common share purchase warrants on a residual values basis as follows: the fair value of the common shares is based on the subscription price of the units issued and the fair value of the common share purchase warrants is determined using the Black-Scholes Option Pricing Model. The fair value of warrants that expire, is reversed to contributed surplus.

 

Income (loss) per share

 

Basic income (loss) per share, net of taxes is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the year. Diluted Net income (loss) per share is calculated by dividing Net income (loss) by the weighted average number of common shares outstanding during the period after giving effect to potentially dilutive financial instruments. The dilutive effect of stock options and warrants is determined using the treasury stock method.

 

Leases

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset over a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether it has the right to obtain substantially all of the economic benefits from the use of the asset during the term of the contract and it has the right to direct the use of the asset.

 

The right-of-use asset is subsequently depreciated from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. The right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date discounted by the interest rate implicit in the lease or, if that rate cannot be readily determined the incremental borrowing rate. The lease liability is subsequently measured at amortized cost using the effective interest method. Lease payments included in the measurement of the lease liability comprise of fixed payments, variable lease payments, and amounts expected to be payable at the end of the lease term.

 

The Company has elected not to recognize the right-of-use assets and lease liabilities for short-term leases that have a lease term of twelve months or less. The lease payments associated with these leases are charged directly to income on a straight-line basis over the lease term.

 

Future standards not yet adopted

 

IFRS 18 Presentation and Disclosure in Financial Statements

 

In April 2024, the IASB issued IFRS 18 Presentation and Disclosure in Financial Statements (“IFRS 18”) which replaces IAS 1 Presentation of Financial Statements. This standard aims to improve how companies communicate in their financial statements, with a focus on information about financial performance in the statement of profit or loss, in particular additional defined subtotals, disclosures about management-defined performance measures and new principles for aggregation and disaggregation of information. IFRS 18 is accompanied by limited amendments to the requirements in IAS 7 Statement of Cash Flows. IFRS 18 is effective from January 1, 2027. Companies are permitted to apply IFRS 18 before that date. The Company is currently assessing the impact the new standard will have on its consolidated financial statements.

 

Page 11

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

3. REVENUE

 

Disaggregated Revenues

 

The Company disaggregates revenue by timing of revenue recognition, that is, at a point in time and revenue over time. During the three months ended March 31, 2026, the Company recognized $503,389 (2025 - $166,760) from non-recurring engineering services and product sales. The NRE is recognized over time while the product sales are recorded at a point in time.

 

4. PREPAIDS AND OTHER CURRENT ASSETS

 

The following table reflects the details of prepaids and other current assets:

 

   March 31,   December 31, 
   2026    2025 

Sales tax recoverable and other current assets

  $550,022   $208,888 
Prepaid expenses   1,006,305    854,640 
   $1,556,327   $1,063,528 

 

5. ACQUISITION

 

On December 31, 2024, the Company acquired Xiamen Sanan Integrated Circuit Co, Ltd.’s (“Sanan IC’s”) 24.8% interest in SPX in exchange for a convertible debt of $6,500,000. The acquisition cost will be paid over a period of five (5) years. The unpaid balances are interest free and will be settled based on the following schedule:

 

October 31, 2025  $700,000 (Paid)
October 31, 2026  $1,000,000 
October 31, 2027  $1,300,000 
October 31, 2028  $1,600,000 
October 31, 2029  $1,900,000 

 

At any time before the convertible debt is fully settled, Sanan IC has the right to convert any remaining unpaid amounts due into shares of common stock of the Company. The conversion shall be executed at a conversion price equal to the greater of: (a) the volume weighted average closing price (“VWAP”) of the common stock of the Company as reported by the NASDAQ Capital Market for thirty (30) days prior to the conversion date, or (b) the closing price of the common stock of the Company as reported by the NASDAQ Capital Market the day prior to the conversion date.

 

The acquisition of Sanan IC’s 24.8% interest in SPX, under which the Company obtains full control over SPX, was determined to be an asset acquisition because SPX did not meet the threshold of a business as defined by IFRS 3.

 

The Company determined that the convertible debt represents a hybrid financial instrument that contains 1) a host debt principal component, 2) a market price conversion feature that is a non-derivative with a value of nil that is not separable from the host debt and, 3) the VWAP conversion option that is a derivative with a nil value. As Sanan IC can exercise the conversion option at any time, the convertible debt is classified as current liability.

 

Page 12

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

5. ACQUISITION (Continued)

 

The assessment of the purchase price allocation on the date of purchase has been determined as follows:

 

Fair value consideration paid    
Convertible debt to be paid over five years  $6,500,000 
      
Recognized amounts of identifiable net assets:     
Cash  $97,833 
Other non-current assets   237,216 
Accounts payable   (388,470)
Payables to the Company   (299,266)
Net assets (liabilities) acquired  $(352,687)
Loss on acquisition  $6,852,687 
   $6,500,000 

 

6. PROPERTY AND EQUIPMENT

  

  Equipment not
in service
  

Leasehold

improvements

   Machinery and
equipment
  

Office 

equipment

   Total 
Cost                         
Balance, January 1, 2025  $8,710,149   $729,523   $9,637,385   $199,073   $19,276,130 
Additions, net of returns   930,036    229,060    1,025,757    70,254    2,255,107 
Disposals   -    -    (30,433)   -    (30,433)
Reclassification   (8,363,829)   -    8,363,829    -    - 
Effect of changes in foreign exchange rates   (9,893)   32,932    187,792    4,985    215,816 
Balance, December 31, 2025   1,266,463    991,515    19,184,330    274,312    21,716,620 
Additions   1,407,651    489,822    468,910    68,542    2,434,925 
Reclassification   (219,517)   166,371    53,146    -    - 
Effect of changes in foreign exchange rates   (8,786)   (7,584)   21,225    (653)   4,202 
Balance, March 31, 2026   2,445,811    1,640,124    19,727,611    342,201    24,155,747 
                          
Accumulated Depreciation                         
Balance, January 1, 2025   -    105,620    6,236,611    176,217    6,518,448 
Depreciation for the year   -    175,662    2,786,708    22,770    2,985,140 
Disposals   -    -    (20,796)   -    (20,796)
Balance, December 31, 2024   -    281,282    9,002,523    198,987    9,482,792 
Depreciation for the period   -    58,182    792,198    10,349    860,729 
Balance, March 31, 2026   -    339,464    9,794,721    209,336    10,343,521 
                          
Carrying Amounts                         
At December 31, 2024  $1,266,463   $710,233   $10,181,807   $75,325   $12,233,828 
At March 31, 2026  $2,445,811   $1,300,660   $9,932,890   $132,865   $13,812,226 

 

Page 13

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

7. PATENTS AND LICENSES

 

Cost    

Balance, January 1, 2025

  $1,335,044 
Additions   46,537 
Balance, December 31, 2025   1,381,581 
Additions   - 
Balance, March 31, 2026   1,381,581 
      
Accumulated Amortization     
Balance, January 1, 2025   728,336 
Amortization during the year   96,870 
Balance, December 31, 2025   825,206 
Amortization during the period   21,945 
Balance, March 31, 2026   847,151 
      
Carrying Amounts     
At December 31, 2025  $556,375 
At March 31, 2026  $534,430 

 

8. RIGHT OF USE ASSET AND LEASE LIABILITY

 

The Company recognizes a lease liability and right of use asset relating to its commercial leases. The lease liability is measured at the present value of the remaining lease payments, discounted using the Company’s incremental borrowing rate of 12% - 16%.

 

Right of use asset  Building 
Cost    

Balance, January 1, 2025

  $1,307,876 
Additions   707,618 
Lease modification   (160,454)
Effect of changes in foreign exchange rates   36,565 
Balance, December 31, 2025   1,891,605 
Effect of changes in foreign exchange rates   2,306 
Balance, March 31, 2026  $1,893,911 

 

Page 14

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

8.RIGHT OF USE ASSET AND LEASE LIABILITY (continued)

 

Accumulated Amortization    
Balance, January 1, 2025  $609,731 
Amortization during the year   233,889 
Lease modification   (64,294)
Balance, December 31, 2025   779,326 
Amortization during the period   75,026 
Balance, March 31, 2026  $854,352 
      
Carrying Amounts     
At December 31, 2025  $1,112,279 
At March 31, 2026  $1,039,559 
      
Lease liability     
Balance, January 1, 2025  $742,418 
Interest expense   144,046 
Additions   690,151 
Lease payments   (223,403)
Lease modification   (109,538)
Effect of changes in foreign exchange rates   22,524 
Balance, December 31, 2025   1,266,198 
Interest expense   46,538 
Lease payments   (93,902)
Effect of changes in foreign exchange rates   1,766 
Balance, March 31, 2026  $1,220,600 
Less: current portion  $(265,256)
Non-current portion  $955,344 

 

9.ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

   March 31,    December 31, 
   2026    2025 
          
Trade payable  $758,446    $1,236,210 
Payroll related liabilities   2,330,986     247,968 
Accrued liabilities   185,965     155,365 
   $3,275,397    $1,639,543 

 

Page 15

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

10.ACCOUNTS RECEIVABLE AND CONTRACT LIABILITIES

 

Revenue Contract Balances

 

   Contract 
   Receivables   Liabilities 
Opening balance, January 1, 2025  $7,257   $- 
Customer deposits   -    1,175,000 
Changes due to payment, fulfillment of performance obligations or other   (732,257)   - 
Revenues recognized   725,000    (725,000)
Effect of changes in foreign exchange rates   -    (4,160)
Balance, December 31, 2025   -    445,840 
Customer deposits   -    230,000 
Revenues recognized   503,389    - 
Changes due to payment, fulfillment of performance obligations or other   (213,021)   (428,335)
Balance, March 31, 2026  $290,368   $247,505 

 

11.SHARE CAPITAL

 

(a)AUTHORIZED
   
  Unlimited number of common shares
   
  One special voting share
   
 (b)COMMON SHARES ISSUED

 

    

Number of

Shares

    Amount 
           
Balance, January 1, 2025   76,507,157   $223,742,335 
Funds from common shares issued on private placement   45,326,019    280,000,001 
Fair value of warrants issued on private placement   -    (88,176,282)
Share issue costs   -    (8,048,167)
Funds from the exercise of stock options   3,944,589    5,441,922 
Fair value of stock options exercised   -    11,513,569 
Funds from the exercise of warrants   6,243,761    15,847,899 
Fair value of warrants exercised   -    30,813,000 
Adjustment due to change in functional currency   -    (28,058,114)
Balance, December 31, 2025   132,021,526    443,076,163 
Funds from the exercise of stock options   182,422    248,245 
Fair value of stock options exercised   -    418,874 
Funds from common shares issued on private placement or public offerings   20,689,656    150,000,006 
Share issue costs   -    (7,657,002)
Balance, March 31, 2026   152,893,604   $586,086,286 

 

Page 16

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

11.SHARE CAPITAL (Continued)

 

The following financings were completed during the period:

 

May 22, 2025

 

On May 22, 2025, the Company raised gross proceeds of CA$41,574,279 ($30,000,000) from the issuance of 6,000,000 units through a non brokered private placement financing at a price CA$6.92 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 6,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.32 ($6.00) per share.

 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 2.96%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $20,077,238.

 

July 17, 2025

 

On July 17, 2025, the Company raised gross proceeds of CA$34,000,000 ($25,000,000) from the issuance of 5,000,000 units through a non brokered private placement financing at a price CA$6.80 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.16 ($6.00) per share.

 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.1%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $16,629,514.

 

October 7, 2025

 

On October 7, 2025, the Company raised gross proceeds of CA$104,625,002 ($75,000,000) from the issuance of 13,636,364 units through a non brokered private placement financing at a price CA$7.67 ($5.50). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$9.78 ($7.03) per share.

 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.71%, volatility of 91.875%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $51,469,530.

 

October 28, 2025

 

On October 28, 2025, the Company raised gross proceeds of $150,000,000 from the issuance of 20,689,655 common shares through a brokered registered direct offering at a price $7.25. The Company paid approximately $7,585,000 in fees related to this offering.The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.1%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $16,629,514.

 

January 23, 2026

 

On January 23, 2026, the Company raised gross proceeds of $150,000,006 from the issuance of 20,689,656 common shares through a brokered registered direct offering at a price $7.25. The Company paid $7,657,002 in fees related to this offering.

 

Page 17

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

12.WARRANTS AND COMPENSATION OPTIONS

 

The following table reflects the continuity of warrants:

 

    

Historical Average

Exercise Price

    

Number of Warrants/

Compensation options

    

Historical Fair value

 
                
Balance, January 1, 2025  $1.05    18,972,338   $11,157,738 
Fair value of warrant issued on private placement   3.34    11,000,000    36,706,752 
Other warrants issued on private placement (1)   -    13,636,364    - 
Adjustment due to change in functional currency   -    -    (15,166,108)
Historical fair value assigned to warrants exercised   1.07    (1,961,733)   (2,098,780)
Other warrants exercised (1)        (4,282,028)   - 
Balance, December 31, 2025   3.77    37,364,941    30,599,602 
Fair value of warrants reclassified from derivative warrant liability   4.57    -    131,444,528 
Balance, March 31, 2026  $4.39    37,364,941   $162,044,130 

 

(1) The fair value of these warrants is included in derivative warrant liability (Note 21).

 

The following table reflects the details of warrants:

 

Expiry Date  Exercise
Price
   Balance
January 1, 2026
   Warrants
Issued
   Warrants
Exercised
   Balance
March 31, 2026
 
Jan 24, 2029   1.09    493,505    -    -    493,505 
Jan 24, 2029   1.11    2,075,682    -    -    2,075,682(1)
May 10, 2029   3.10    2,048,275    -    -    2,048,275(1)
July 19, 2029   4.00    3,333,334    -    -    3,333,334 
Sep 25, 2029   5.00    2,000,000    -    -    2,000,000 
Dec 4, 2029   6.00    2,777,778    -    -    2,777,778 
May 22, 2030   6.06    6,000,000    -    -    6,000,000(1)
Jul 17, 2030   5.94    5,000,000    -    -    5,000,000(1)
Oct 7, 2030   7.12    13,636,364    -    -    13,636,364(1)
     $1.09 - $7.12    37,364,938    -    -    37,364,938 

 

(1) These warrants were initially priced in CAD and their fair values were classified as derivative warrant liability at December 31, 2025. On March 6, 2026, they were repriced from CAD into USD on the basis of a currency exchange rate of US$1.00 = CAD$0.7285, representing the three month average currency exchange rate posted by the Bank of Canada as of the close of business on March 6, 2026. Their fair value on that date was reclassified to warrants.

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS

 

Stock Options

 

On June 27, 2025, shareholders of the Company approved the amendment to the Company’s fixed 20% omnibus equity incentive plan (the “Omnibus Plan”). The Omnibus Plan provides flexibility to the Company to grant different forms of equity based incentive awards to directors, officers, employees and consultants. The Omnibus plan provides the Company with the choice of granting stock options (“Options”), share units (“Share Units”) and deferred share units (“DSUs”). The Omnibus Plan provides that the maximum number of common shares issuable pursuant to awards granted under the Omnibus Plan and pursuant to other previously granted awards is limited to 16,696,252 (the “Number Reserved”). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. Awards vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the Omnibus Plan which grants discretion to the Board of Directors.

 

Page 18

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)

 

Stock option transactions and the number of stock options outstanding were as follows:

 

    

Number of

Options

    

Historical

Weighted average

Exercise Price

 
Balance, January 1, 2025   9,562,224   $1.47 
Expired/cancelled   (345,091)   2.38 
Exercised   (3,944,589)   1.43 
Granted   555,000    5.13 
Balance, December 31, 2025   5,827,544    1.93 
Expired/cancelled   (3,125)   1.79 
Exercised   (182,422)   1.36 
Granted   150,000    6.33 
Balance, March 31, 2026   5,791,997   $2.06 

 

During the three months ended March 31, 2026, the Company granted 150,000 (three months ended March 31, 2025 - 155,000) stock options to employees and consultants of the Company to purchase common shares at an average price of $6.33 (three months ended March 31, 2025 - $3.69) per share.

 

During the three months ended March 31, 2026, the Company recorded stock-based compensation of $3,486,766 (three months ended March 31, 2025 - $841,793) relating to stock options and RSUs.

 

The stock options granted and re-priced were valued using the Black-Scholes option pricing model using the following assumptions:

 

Three Months Ended March 31,   2026    2025 
           
Weighted average exercise price  $6.33   $3.69 
Weighted average risk-free interest rate   4.18%   3.02%
Weighted average dividend yield   0%   0%
Weighted average volatility   90.24%   87.12%
Weighted average estimated life   10 years    10 years 
Weighted average share price  $6.33   $3.69 
Share price on the various grant dates:  $6.33   $3.69 
Weighted average fair value  $5.54   $3.16 

 

The underlying expected volatility was determined by reference to the Company’s historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options.

 

Page 19

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)

 

The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at March 31, 2026 are as follows:

 

Options Outstanding   Options Exercisable 

Exercise

  

Number

  

Historical Weighted

Average Exercise

  

Weighted Average

Remaining Contractual

  

Number

  

Historical Weighted

Average Exercise

 
Range   Outstanding   Price   Life (years)   Exercisable   Price 
                      
 $0.76 - $1.27    2,845,889   $1.27    6.01    2,049,261   $1.27 
 $1.28 - $3.03    1,722,285   $1.69    8.17    988,234   $1.63 
 $3.04 - $6.65    1,223,823   $4.40    8.90    251,323   $4.00 
      5,791,997   $2.06    7.27    3,288,818   $1.58 

 

Restricted Share Units (RSUs)

 

During the year  three months ended March 31, 2026, the Company granted 79,669 RSUs to directors, officers and employees under the the Company’s Omnibus Plan. The RSUs were granted at a weighted average fair value of $6.33 per unit. The RSUs granted during the period will vest 33% yearly over three years.

 

Details of the RSU grants are as follows:

 

  

Weighted Average

Grant Price ($)

   Number 
Opening balance, January 1, 2026   5.45    3,183,038 
Granted   6.33    79,669 
March 31, 2026        3,262,707 

 

14.LOSS PER SHARE

 

  

Three Months Ended

March 31,

 
   2026   2025 
Basic income (loss) per share        
Numerator        
Net income (loss)  $(12,344,086)  $6,341,558 
Denominator          
Weighted average number of common shares outstanding - basic   147,523,126    77,538,957 
Basic income (loss) per share  $(0.08)  $0.08 
           
Numerator          
Adjusted net income (loss)  $-   $(301,210)
Denominator          
Effect of dilutive securities          
Warrants   -    699,831 
Weighted average number of common shares outstanding - diluted   147,523,126    78,238,788 
Diluted income (loss) per share  $(0.08)   $0.08 

 

Page 20

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

15.COMMITMENTS AND CONTINGENCIES

 

The Company has operating leases on three facilities; head office located in Toronto, Canada, and operating facilities located in Singapore and China. The lease on the Company’s operating facilities in Singapore terminated on March 31, 2025. The Company has expanded its operating facilities in Singapore, as a result it entered into a lease arrangement on October 1, 2024, expiring March 1, 2030. A security deposit in the amount of $208,125 was placed with the landlord. The lease on the Company’s operating facilities in China terminated in January 2025. The company entered into a new lease on December 20, 2024, which expires on December 19, 2027. As of March 31, 2026, the Company’s head office was on a month-to-month lease term.

 

Remaining minimum annual rental payments to the lease expiration dates are as follows:

 

April 1, 2026 to December 31, 2026  $324,278 
2027 and beyond   1,383,023 
   $1,707,301 

 

16.RELATED PARTY TRANSACTIONS

 

Compensation to key management personnel were as follows:

 

  

Three Months Ended

March 31,

 
   2026   2025 
         

Salaries

  $5,144,838   $1,956,222 
Share-based payments (1)   2,247,924    690,323 
Total  $7,392,762   $2,646,545 

 

(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various periods as calculated using the Black-Scholes model.

 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

 

17.SEGMENT INFORMATION

 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semiconductor products and services for commercial applications. The Company’s operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company’s operations is below:

 

OPEL, ODIS, POET Shenzhen, PTM, SPX and PTS

 

OPEL, ODIS, POET Shenzhen, PTM, SPX and PTS are the designers and developers of the POET Optical Interposer platform and optical engines based on the POET Optical Interposer platform.

 

BB Photonics

 

BB Photonics developed photonic integrated components for the datacom and telecom markets utilizing embedded dielectric technology that enabled the partial integration of active and passive devices into photonic integrated circuits. BB Photonics’ operation is currently dormant.

 

Page 21

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

17.SEGMENT INFORMATION (Continued)

 

On a consolidated basis, the Company operates geographically in China and Singapore (collectively “Asia”), the United States and Canada. Geographical information is as follows:

 

   2026 
As of March 31,  Asia   US   Canada   Consolidated 
Current assets  $1,980,859   $375,370    $428,626,908    $430,983,137 
Long term deposit   208,125    -    -    208,125 
Loan receivable   -    -    15,194,384    15,194,384 
Property and equipment    13,537,494    274,732    -    13,812,226 
Patents and licenses   -    534,430    -    534,430 
Right of use assets   1,039,559    -    -    1,039,559 
Total Assets  $16,766,037   $1,184,532   $443,821,292   $461,771,861 

 

For the Three Months Ended March 31,  Asia   US   Canada   Consolidated 
                 

Revenue

  $503,389   $-   $-   $503,389 
Selling, marketing and administration   (1,781,033)   (5,641,787)   (5,110,393)   (12,533,213)
Research and development   (5,090,930)   (693,494)   (55,910)   (5,840,334)
Interest expense   (46,517)   -    -    (46,517)
Fair value adjustment to derivative warrant liability   -    -    1,602,298    1,602,298 
Other income, including Interest   -    -    3,970,291    3,970,291 
Net income (loss)  $(6,415,091)  $(6,335,281)  $406,286   $(12,344,086)

 

   2025 
As of December 31,  Asia   US   Canada   Consolidated 
Current assets
  $1,325,632   $358,665   $312,777,534   $314,461,831 
Long-term deposit   208,125    -    -    208,125 
Property and equipment   11,914,787    319,041    -    12,233,828 
Patents and licenses   -    556,375    -    556,375 
Right of use assets   1,112,279    -    -    1,112,279 
Total Assets  $14,560,823   $1,234,081   $312,777,534   $328,572,438 

 

For the Three Months Ended March 31,  Asia   US   Canada   Consolidated 
Revenue
  $166,760   $-   $-   $166,760 
Selling, marketing and administration   (1,102,900)   (2,601,952)   (1,484,210)   (5,189,062)
Research and development   (4,124,717)   (351,942)   (37,448)   (4,514,107)
Interest
   (32,227)   (559)   -    (32,786)
Fair value adjustment to derivative warrant liability
   -    -    15,382,971    15,382,971 
Other income, including interest and loan forgiveness   10,024    -    517,758    527,782 
Net income (loss)  $(5,083,060)  $(2,954,453)  $14,379,071   $6,341,558 

 

Page 22

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

18.FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Company’s financial instruments consist of cash and cash equivalents, short-term investments, accounts receivable, loan receivable, convertible debt, derivative warrant liability and accounts payable and accrued liabilities. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that carrying value of these instruments approximates fair value due to their short term nature.

 

The Company has classified financial assets and (liabilities) as follows:

 

  

March 31,

2026

  

December 31,

2025

 
Financial assets, measured at amortized cost:          
Cash and cash equivalents  $16,537,393   $39,959,201 
Short-term investments  $412,599,049   $273,439,102 
Accounts receivable  $290,368   $- 
Finacial assets, measured at fair value through profit or loss (FVPTL):
Loan receivable (1)  $15,194,384   $- 
Other liabilities, measured at amortized cost:          
Accounts payable and accrued liabilities  $(3,275,397)  $(1,639,543)
Convertible debt  $(5,800,000)  $(5,800,000)
Financial liabilities, measured at fair value through profit or loss (FVTPL):          
Derivative warrant liability  $(2,584,759)  $(135,631,585)

 

(1) Financial instruments recorded at fair value on the balance sheet are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

 

Level 1 - valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

 

Level 2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly.

 

Level 3 - valuation techniques based on inputs for the asset or liability that are not based on observable market data.

 

The Company uses Level 3 fair value hierarchy to determine the value of its loan receivable due to the unobservable inputs, including assumptions relating to borrower financing outcomes, strategic transaction probabilities and conversion features.

 

Exchange Rate Risk

 

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled. Functional currencies include the Chinese Yuan, US, Singapore and Canadian dollar. Most transactions within the entities are conducted in functional currencies. As such, none of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk when its subsidiaries hold current assets or current liabilities in currencies other than its functional currency. A 10% change in foreign currencies held would increase or decrease other comprehensive loss by $1,742,000.

 

Liquidity Risk

 

The Company currently does not maintain credit facilities. The Company’s existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the date of these consolidated financial statements. The Company may, however, need to seek additional financing in the future.

 

Page 23

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

19.CAPITAL MANAGEMENT

 

In the management of capital, the Company includes shareholders’ equity (excluding accumulated other comprehensive loss and deficit) and cash and cash equivalents and short-term investments. The components of capital on March 31, 2026 were:

 

Cash and cash equivalents and short-term investments  $429,136,442 
Shareholders’ equity (excluding deficit and other comprehensive loss)  $760,528,032 

 

The Company’s objective in managing capital is to ensure that financial flexibility is present to increase shareholder value through growth and responding to changes in economic and/or market conditions; to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business and to safeguard the Company’s ability to obtain financing should the need arise.

 

In maintaining its capital, the Company has an investment policy which includes investing its surplus capital only in highly liquid, highly rated financial instruments. The Company reviews its capital management approach on an ongoing basis. There are no external restrictions on the management of capital and no changes to the Company’s capital management process for the period ended March 31, 2026.

 

20.EXPENSES

 

Research and development costs can be analysed as follows:

 

  

Three Months Ended

March 31,

 
   2026   2025 
Wages and benefits  $1,927,390   $2,187,550 
Subcontract fees   443,580    627,710 
Stock-based compensation   1,340,778    153,915 
Supplies   2,128,586    1,544,932 
   $5,840,334   $4,514,107 
           

Selling, marketing and administration costs can be analysed as follows:

          
Stock-based compensation  $2,145,988   $687,878 
Wages and benefits   4,046,941    2,123,274 
General expenses   1,687,317    814,497 
Professional fees   320,430    276,184 
Depreciation and amortization   957,700    726,868 
Finance and advisory fees   3,252,500    476,802 
Rent and facility costs   122,337    83,559 
   $12,533,213   $5,189,062 

 

21.DERIVATIVE WARRANT  LIABILITY

 

January 24, 2024

 

On January 24, 2024, the Company raised gross proceeds of CA$6,219,667 ($4,613,312) from the issuance of 5,098,088 units through a private placement financing facility at an offering price CA$1.22 ($0.90). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,098,088 common shares for a period of five (5) years from the date of closing at a price of CA$1.52 ($1.12) per share.

 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.5%, volatility of 78.35%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $2,815,861. The remaining 3,381,025 warrants were remeasured using the Black-Scholes option pricing model on October 1, 2025, being the date the Company changed its functional currency from Canadian Dollars to United States Dollars. The estimated fair value on the remeasurement date was $16,447,723.

 

Page 24

 

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

21.DERIVATIVE WARRANT LIABILITY

 

On March 6, 2026, 2,075,682 warrants were repriced from CA$1.52 to USD$1.11. The remaining 493,505 warrants continue to be carred as a derivative warrant liability is periodically remeasured. The estimated fair value on the remeasurement date was $2,584,759.

 

The following table presents the details of the derivative warrant liability:

 

    

March 31,

2026

    December 31,
2025
 
Stock price  $5.94   $6.33 
Exercise price range  $1.52    $1.09 - $6.00 
Expected life in years   2.82    3.07 - 4.77 
Volatility   107.37%   93.70% - 105.78% 
Dividend yield   0%   0%
Risk free interest rate   3.59%   3.55%
Fair value of derivative warrant liability  $2,584,759   $135,631,585 
Warrants   493,505    29,274,826 

 

22.LOAN RECEIVABLE

 

On January 7, 2026 and January 21, 2026, the Company made two loans of $10,000,000 and $5,000,000 (collectively, the “Loan”) respectively to a company (the “Borrower”) to be used for general working capital purposes. The loan bears interest from the initial issue date until its repayment in full when not in default at the per annum rate of six percent (6.0%), compounded daily. Upon the occurrence and during the continuance of a default, the principal and any accrued interest will bear interest at eight percent (8.0%) until the default is cured or waived.

 

The Loan and accrued interest are payable on the earlier of (a) the closing of a Liquidity Event; and (b) five (5) years from the initial issue date. Liquidity Events include mergers, amalgamations, reorganizations, consolidations or other transaction involving the Borrower. The Borrower has the right to repay the loan and accrued interest without penalty prior to the maturity date. If certain events occur, the Company will have the right to convert the unpaid loan and accrued interest into equity securities of the Borrower.

 

23.SUBSEQUENT EVENTS

 

a)Loan receivable

 

On April 23, 2026, the Company advanced another $15,000,000 to the Borrower to be used for general working capital purposes on the same terms as the loans made on January 7 and 21 2026 as outlined in Note 22.

 

b)Legal Actions

 

Subsequent to March 31, 2026, in the ordinary course of business, the Company was threatened with and named as defendants to a pending legal action. The Company does not believe that the ultimate outcome of these and any outstanding matters will have a material effect upon our operations, financial position, results of operations or cash flows. The Company is assessing its response to this legal action.

 

Page 25